Navigation Links
Callibra, Inc. dba Discharge 1-2-3™ is Named Top 75 Nominee for 10th Annual Chicago Innovation Awards
Date:10/5/2011

CHICAGO, Oct. 5, 2011 /PRNewswire/ -- Callibra, Inc. dba Discharge 1-2-3 of Schaumburg, IL, has been selected as one of the 75 nominees for the 2011 Chicago Innovation Awards.  The ten winners will be announced Tuesday, November 8th and celebrated at an event at Chicago's Harris Theater that evening.

The Chicago Innovation Awards, celebrating its 10th year, is the Chicago region's foremost recognition of the most innovative new products or services brought to market or to public service each year.  There were more than 400 nominees for the 2011 Chicago Innovation Awards, representing an increase of more than 60 percent over the past two years.

The innovation nominated by Callibra, Inc. is the Discharge 1-2-3 Composer™ which utilizes patent pending technology, and allows Emergency Physicians and staff fast point-and-click creation of custom patient discharge instructions in multiple languages.  The software will be available standalone and is currently available as part of Allscripts ED . “We are extremely pleased and honored by recognition for our work in information technology and clinical workflow automation that accelerates and enhances effective doctor – patient communication at the time of discharge,” said Dr. Christopher Galassi, CEO and Technical Director at Callibra, Inc. www.Discharge123.com

"The most important message of the Chicago Innovation Awards is one of confidence and courage," said Thomas D. Kuczmarski, co-founder with Chicago journalist Dan Miller of the awards.  "The economy is challenging but each nominee believes the simple truth that a powerful new product will find a rewarding market and has the courage to pursue their vision."

Each year ten winners are chosen from among the 75 finalists by a panel of judges reflecting a cross section of Chicago's business community.  In addition, each of the 75 finalists is automatically in the running for the annual "People's Choice Award," selected through online balloting at www.chicagoinnovationawards.com.

The finalists are also each awarded a scholarship to attend a day-long executive education program titled "The Practical Innovator," taught at Northwestern University's Kellogg School of Management.

About Callibra, Inc.:

Headquartered in the Chicago suburb of Schaumburg, IL, Callibra, Inc. develops health information technology software for emergency departments, hospitals, urgent care, and clinic settings. Since its launch in 2002, the company's flagship product, Discharge 1-2-3 has achieved rapid and eager acceptance by leading healthcare organizations nationwide.  Discharge 1-2-3 instructions contained in the software are also available for use in other systems from vendors such as Epic, Allscripts, and PICIS to name a few. Instructions are professionally written to be comprehensive, highly accurate, clear and understandable. Discharge 1-2-3 is certified as an ONC-ATCB 2011/2012 EHR Module and meets "Meaningful Use" requirements for electronic discharge instructions, patient education and medication reconciliation.


'/>"/>
SOURCE Callibra, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Discharge of First U.S. DuraHeart(TM) Patient
2. Results and Additional Analyses From Study Show That Cortheras Relaxin for Acute Heart Failure is the Strongest Predictor of Improved Longer-Term Outcomes Following Hospital Discharge When Compared to Other Variables
3. Texas Childrens Hospital Discharges History-Making Teen Patient Again; This Time With a Transplanted Heart Replacing Mechanical Device
4. UKs 1st Total Artificial Heart Patient Discharged Home Using Freedom® Portable Driver
5. Aspirin Named 8th World Wonder by Majority of Americans
6. American Board of Internal Medicine President Named to Alzheimers Study Group
7. New York Infection Prevention Expert Named Recipient of Carole DeMille Award
8. Pharmaxis Establishes Named Patient Program for Bronchitol
9. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
10. Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programmes
11. Battelle Scientists Named on Patent for Making Oxygen From Light and Water
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology:
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
Breaking Medicine News(10 mins):